- Poster presentation
- Open access
- Published:
Bronchoalveolar lavage/blood ratio of surface TREM-1 on CD14-positive monocytes is diagnostic of ventilator-associated pneumonia
Critical Care volume 15, Article number: P281 (2011)
Introduction
Biomarkers offer the possibility to speed up diagnosis of ventilator-associated pneumonia (VAP) and differentiate it from nonpulmonary infection. One such marker, the triggering receptor expressed on myeloid cells-1 (TREM-1), exists as a soluble protein and a surface receptor expressed on monocytes and neutrophils [1]. The purpose of the study was to determine the diagnostic utility of surface TREM-1 levels in VAP.
Methods
Paired bronchoalveolar lavage (BAL) and blood were obtained from 25 VAP patients, 15 ventilated non-infected controls, 10 ventilated patients with nonpulmonary infection and 25 nonventilated controls. VAP diagnosis was by clinical pulmonary infection score (CPIS) and semiquantitative microbiology. BAL and blood monocytic and neutrophilic levels of surface TREM-1 and CD11b (leukocyte activation marker) were assessed using flow cytometry. Monocytes were CD14-positive. Soluble TREM-1, IL-1β, IL-6 and IL-8 were measured using ELISA. BAL dilution was corrected by urea assay.
Results
See Figure 1. The BAL level of monocytic surface TREM-1 was elevated in VAP. For ventilated patients, the area under the ROC curve (AUC) was 0.87 for diagnosing VAP, with sensitivity 72% and specificity 80%. Blood levels did not differ between the groups. However, the BAL/blood ratio improved diagnostic accuracy further. The AUC was 0.97, sensitivity 84%, specificity 92% and positive likelihood ratio 10.5. The ratio differentiated pulmonary from nonpulmonary infection. The BAL/blood ratio of monocytic CD11b was 0.78. The BAL levels of neutrophil surface TREM-1, soluble TREM-1, IL-1β and IL-8 had AUCs of 0.75, 0.76, 0.81 and 0.85, respectively.
BAL/blood monocytic TREM-1 ratio.
Conclusions
The BAL/blood ratio of monocytic surface TREM-1 diagnoses VAP and differentiates pulmonary from nonpulmonary infection. CD14 and TREM-1 may have a role in the pathogenesis of VAP.
References
Bouchon A, et al.: J Immunol. 2000, 164: 4991-4995.
Author information
Authors and Affiliations
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Grover, V., Kelleher, P., Henderson, D. et al. Bronchoalveolar lavage/blood ratio of surface TREM-1 on CD14-positive monocytes is diagnostic of ventilator-associated pneumonia. Crit Care 15 (Suppl 1), P281 (2011). https://doi.org/10.1186/cc9701
Published:
DOI: https://doi.org/10.1186/cc9701